MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
HTG Molecular Diagnostics DIO Ratio 2011-2026 | HTGM
Annual DIO Ratio HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 116 | 155 | 136 | 52 | 93.7 | 86.7 | 133 | 241 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 241 | 52 | 127 |
Quarterly DIO Ratio HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 248 | 179 | 214 | - | 216 | 184 | 180 | - | 145 | 140 | 124 | - | 39.4 | 46.2 | 57.5 | - | 96.2 | 82.2 | 99.8 | - | 98.9 | 87.1 | 94.8 | - | 123 | 148 | 201 | - | 248 | 241 | 198 | - | 206 | 250 | 120 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 250 | 39.4 | 151 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
97.1 | $ 115.48 | 0.82 % | $ 35.1 B |  USA |
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 16.2 | -0.61 % | $ 175 M |  China |
 |
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
1.69 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 24.84 | -0.84 % | $ 690 M | USA |
 |
DarioHealth Corp.
DRIO
|
171 | $ 8.4 | 3.7 % | $ 33.5 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
BioNano Genomics
BNGO
|
251 | $ 1.2 | 0.84 % | $ 6.53 M | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 173.89 | -0.58 % | $ 8.62 B | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
DexCom
DXCM
|
115 | $ 62.22 | -0.24 % | $ 24.3 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 16.82 | 2.31 % | $ 509 M | USA |
 |
Biomerica
BMRA
|
147 | $ 2.17 | -0.91 % | $ 4.98 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 198.02 | 0.17 % | $ 22 B | USA |
 |
Guardant Health
GH
|
82.1 | $ 93.83 | 2.94 % | $ 11.8 B | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 76.1 | 0.53 % | $ 5.14 B | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
29.1 | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 259.94 | -1.11 % | $ 26 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 114.19 | 2.49 % | $ 9.42 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
84.3 | $ 569.55 | 0.87 % | $ 45.8 B | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 9.41 | 0.21 % | $ 2.04 B | USA |
 |
Illumina
ILMN
|
137 | $ 127.38 | 0.59 % | $ 20.3 B | USA |
 |
Pacific Biosciences of California
PACB
|
173 | $ 1.34 | -0.74 % | $ 402 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.11 | -0.66 % | $ 20 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | Israel |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 273.72 | 0.36 % | $ 22.8 B | USA |
 |
Myriad Genetics
MYGN
|
42.8 | $ 4.75 | 3.49 % | $ 440 M | USA |
 |
Sotera Health Company
SHC
|
36.5 | $ 14.96 | 0.61 % | $ 4.25 B | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 8.0 | 3.23 % | $ 1.02 B | USA |